Clinical trial

Study of Dapansutrile Capsules in Heart Failure

NCT03534297

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-05-16

PhasePHASE1

Study timeline

Study start (actual)2018-05-16Date precision: day

Registry last updated2020-01-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Systolic Heart Failureunresolved

Interventions

dapansutrile capsulesDRUG

Placebo capsulesDRUG

Sponsors & collaborators

Olatec Therapeutics, Inc.lead sponsor

Mapped research locations

RichmondVirginia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03534297 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.